What is the appropriate diazepam (diazepam) tapering regimen for a patient who is discontinuing alprazolam (Xanax)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diazepam Taper for Alprazolam Discontinuation

Use a gradual diazepam taper reducing the dose by 25% every 1-2 weeks, with the understanding that slower tapers (10% per month or less) are better tolerated and may be necessary for long-term benzodiazepine users. 1

Conversion and Initial Dosing

First, convert the patient's current alprazolam dose to diazepam equivalent:

  • Alprazolam 0.5 mg = Diazepam 5 mg (approximate 1:10 ratio)
  • Calculate total daily alprazolam dose and multiply by 10 to get diazepam equivalent
  • Start with this equivalent dose of diazepam divided into 2-3 daily doses

The rationale for using diazepam is its longer half-life compared to alprazolam, which provides more stable blood levels and reduces the severity of interdose withdrawal symptoms.

Tapering Schedule

Standard approach (25% reduction every 1-2 weeks):

  • Reduce the total daily diazepam dose by 25% every 1-2 weeks 1
  • This schedule has been used safely with moderate success in clinical practice
  • Monitor closely for withdrawal symptoms: anxiety, insomnia, tremor, diaphoresis, tachycardia, or seizures

Slower approach for long-term users (recommended):

  • For patients on benzodiazepines ≥1 year, use 10% reductions per month or slower 2
  • This hyperbolic tapering approach is better tolerated than linear reductions 3, 4
  • The pharmacologic rationale: GABA-A receptor occupancy follows a hyperbolic curve, so equal dose reductions produce increasingly large pharmacological effects at lower doses

Critical Monitoring Points

Withdrawal symptoms requiring taper adjustment:

  • Rebound anxiety, hallucinations, seizures, delirium tremens (rare but potentially fatal) 1
  • If significant withdrawal occurs, pause the taper or return to the previous dose 2
  • Clinically significant withdrawal signals the need to slow the taper rate further

Follow-up frequency:

  • At least monthly during active tapering 2
  • More frequent contact (weekly or biweekly) may be needed during difficult phases

Adjunctive Support

Add cognitive behavioral therapy (CBT):

  • CBT increases tapering success rates 1
  • Particularly helpful for patients struggling with the taper

Alternative anxiety management:

  • If benzodiazepines were prescribed for anxiety, offer evidence-based alternatives: CBT, antidepressants (SSRIs/SNRIs), or other non-benzodiazepine medications 1
  • Do not leave anxiety untreated during the taper

Special Considerations

Very low final doses:

  • The last doses may need to be extremely small (as low as 0.2 mg diazepam equivalent) 3
  • Use liquid formulations or compounded preparations to achieve these micro-doses 4
  • This prevents the final "step down" from being disproportionately large in pharmacological effect

High-dose benzodiazepine users:

  • For patients abusing high doses, start with a loading dose of approximately 40% of reported daily consumption, then taper by 10% daily 5
  • This applies to inpatient detoxification settings with close monitoring

Common Pitfalls to Avoid

  1. Too-rapid tapering: Linear dose reductions (e.g., 5 mg every week) produce escalating withdrawal at lower doses due to hyperbolic receptor pharmacology
  2. Abrupt discontinuation: Can cause seizures, delirium, and rarely death 1
  3. Ignoring withdrawal symptoms: These signal the need to slow or pause the taper
  4. Abandoning patients: If disagreement occurs about tapering pace, maintain the therapeutic relationship and adjust the plan collaboratively 2
  5. Inadequate final dose reductions: Failing to use very small doses at the end makes the last step disproportionately difficult

The taper duration should be individualized based on withdrawal severity, with some patients requiring months to years to complete the process safely. Patient agreement and shared decision-making are essential for success 2, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.